Erythromycin propionate

Erythromycin propionate, erythromycin (HY-B0220) derivative[1], is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin propionate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin propionate toxicity is related to its inhibitory effect on bile acid transport[2].

Product Specifications

CAS Number

[134-36-1]

UNSPSC

12352005

Target

Aminotransferases (Transaminases) ; Antibiotic; Bacterial; Dengue Virus; Flavivirus

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection

Smiles

CCC(O[C@H]([C@H](C[C@H](O1)C)N(C)C)[C@@H]1O[C@@H]2[C@H]([C@@H]([C@H](C(O[C@@H]([C@@](O)([C@@H]([C@H](C([C@@H](C[C@]2(O)C)C)=O)C)O)C)CC)=O)C)O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)O)OC)C)=O